Pharmaceuticals, Biotechnology and Life Sciences
The Board of Ovoca Bio, an international biopharmaceutical company focusing on women’s health, has issued a statement in response to events in Ukraine and Russia.
Tollys has entered into a sponsored research agreement with Gustave Roussy.
The U.S. Food and Drug Administration had approved the expanded use of Opdivo, BMS’s cancer drug for patients with an aggressive form of lung cancer.
Oncimmune Holdings has signed a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing on the autoantibody profiling of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”).
Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering…
Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the…
Roche have announced an initial donation of essential medicines to Ukraine, after the country has been violently invaded by Russia.…
NEWTON, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,…
MiGenTra, headquartered in Berlin, Germany and MiGenTra Egypt, located with its ‘Facility of the Future’ in Cairo, Egypt, have announced…
Oculis and Accure Therapeutics have announced a licensing agreement granting Oculis exclusive global rights to develop and commercialize ACT-01, a…